104 related articles for article (PubMed ID: 11162616)
1. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.
Lee MH; Knäuper V; Becherer JD; Murphy G
Biochem Biophys Res Commun; 2001 Jan; 280(3):945-50. PubMed ID: 11162616
[TBL] [Abstract][Full Text] [Related]
2. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
Lee MH; Dodds P; Verma V; Maskos K; Knäuper V; Murphy G
Biochem J; 2003 Apr; 371(Pt 2):369-76. PubMed ID: 12556225
[TBL] [Abstract][Full Text] [Related]
3. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3.
Lee MH; Verma V; Maskos K; Becherer JD; Knäuper V; Dodds P; Amour A; Murphy G
FEBS Lett; 2002 Jun; 520(1-3):102-6. PubMed ID: 12044879
[TBL] [Abstract][Full Text] [Related]
5. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
Wei S; Xie Z; Filenova E; Brew K
Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
7. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
[TBL] [Abstract][Full Text] [Related]
8. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
[TBL] [Abstract][Full Text] [Related]
9. Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering.
Lee MH; Maskos K; Knäuper V; Dodds P; Murphy G
Protein Sci; 2002 Oct; 11(10):2493-503. PubMed ID: 12237470
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
Wisniewska M; Goettig P; Maskos K; Belouski E; Winters D; Hecht R; Black R; Bode W
J Mol Biol; 2008 Sep; 381(5):1307-19. PubMed ID: 18638486
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the metalloproteinase domain of mouse TACE.
Amour A; Hutton M; Knäuper V; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Docherty AJ; Murphy G
Ann N Y Acad Sci; 1999 Jun; 878():728-31. PubMed ID: 10415820
[No Abstract] [Full Text] [Related]
13. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
[TBL] [Abstract][Full Text] [Related]
14. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
15. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE).
Li X; Fan H
J Biol Chem; 2004 Jun; 279(26):27365-75. PubMed ID: 15075334
[TBL] [Abstract][Full Text] [Related]
16. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
17. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.
Hansen HP; Dietrich S; Kisseleva T; Mokros T; Mentlein R; Lange HH; Murphy G; Lemke H
J Immunol; 2000 Dec; 165(12):6703-9. PubMed ID: 11120787
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
[TBL] [Abstract][Full Text] [Related]
19. IK682, a tight binding inhibitor of TACE.
Niu X; Umland S; Ingram R; Beyer BM; Liu YH; Sun J; Lundell D; Orth P
Arch Biochem Biophys; 2006 Jul; 451(1):43-50. PubMed ID: 16762314
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
